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Abstract
Background: Approximately 4–6% of incident end stage renal disease (ESRD) patients in the U.S. recover enough
kidney function to discontinue dialysis but there is considerable geographic variation. We undertook this study to
investigate whether state-level variations in renal recovery among incident ESRD patients correlated with state-level
variations in incidence of acute kidney injury requiring dialysis (AKI-D).
Methods: We conducted a national cross-sectional ecological study at the state-level using data from State Inpatient
Databases and U.S. Renal Data System. All hospital admissions and all ESRD patients in 18 US states (AZ, AR, CA, FL, IA,
KY, MA, MD, MI, NJ, NM, NY, NV, OR, RI, SC, VT, and WA) were included. Correlation between AKI-D incidence and rate
of renal recovery across states was determined using Pearson’s r (overall and in subgroups). We also calculated partial
correlations adjusted for sex and age.
Results: AKI-D incidence ranged from 99.0 per million population (pmp) in Vermont to 490.4 pmp in Nevada. Rate of
renal recovery among incident ESRD patients ranged from 8.8 pmp in Massachusetts to 29.3 pmp in Florida. A positive
correlation between AKI-D incidence and rate of renal recovery among incident ESRD patients at state level was found
overall (unadjusted r = 0.67; p = 0.002) and in age, sex, and race subgroups. The overall correlation persisted after
adjusting for age (adjusted r = 0.62; p < 0.001) and sex (adjusted r = 0.65; p < 0.001).
Conclusion: Our findings suggest that AKI-D incidence is an important driver of renal recovery rates among incident
ESRD patients.
Keywords: AKI-D, ESRD, Renal recovery
Background
Recent studies suggest that the rate of renal recovery
among patients on maintenance dialysis has increased
over the last two decades such that 4–6% of contempor-
ary patients registered with incident end stage renal
disease (ESRD) in the United States become dialysis in-
dependent within 1 year [1, 2]. This somewhat surprising
observation may reflect an increasing number of patients
entering the ESRD program after acute kidney injury
(AKI) requiring dialysis (AKI-D) who subsequently
recovered kidney function over a period of months.
Prior research also reported geographic variation in
renal recovery rates among incident ESRD patients in
the United States [2] but the reasons behind this
observation are not well understood. Therefore, we
undertook this study to investigate whether state-level
variations in AKI-D correlated with state-level varia-
tions in renal recovery among incident ESRD patients.
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Methods
Study design
We conducted a national, cross-sectional, ecologic study
of AKI-D and renal recovery among incident ESRD
patients in the United States.
Determination of number of AKI-D hospitalizations at
state level
We used State Inpatient Databases (SID) to determine
the number of AKI-D hospitalizations [3]. SID are part
of the family of databases and software tools developed
for the Healthcare Cost and Utilization Project (HCUP),
developed through a U.S. Federal-State-Industry partner-
ship. The SID contain the universe of the inpatient
discharge abstracts in participating States, translated into
a uniform format to facilitate multi-State comparisons
and analyses. The SID contain a core set of clinical and
nonclinical information on all patients, regardless of
insurance satus [3–5].
Although there were 30 SID databases available for
2011, we only had financial resources to purchase 25 of
them. We selected a convenience sample of 25 of the
larger states by geographic region (which captured 90%
of discharges): Arizona (AZ), Arkansas (AR), California
(CA), Colorado (CO), Florida (FL), Iowa (IA), Kentucky
(KY), Massachusetts (MA), Maryland (MD), Maine
(ME), Michigan (MI), Mississippi (MS), North Carolina
(NC), Nebraska (NE), New Jersey (NJ), New Mexico
(NM), New York (NY), Nevada (NV), Oregon (OR),
Rhode Island (RI), South Carolina (SC), Utah (UT),
Vermont (VT), Washington (WA), and West Virginia
(WV)(Additional file 1: Figure S1). The different state
databases varied in capturing whether a diagnosis was
present on admission or not and in indicating whether
an admission represented a re-admission to the hospital
for the same patient in a given calendar year.
We defined AKI-D as requiring both a diagnostic code
for acute renal failure (International Classification of
Diseases, Ninth Revision, Clinical Modification [ICD-9]
codes 584.5, 584.6, 584.7, 584.8, or 584.9) and a proced-
ure code for dialysis (39.95, V45.11, V45.12, V56.0, or
V56.2), along with the absence of procedure codes for
arteriovenous fistula creation or revision (39.27, 39.42,
39.43, or 39.93) [6–8]. This algorithm has been shown to
be sensitive and specific, producing high positive and
negative predictive values (all ≥90%) [6–8].
To address potential ascertainment bias arising from
the fact that states reported different numbers of diag-
nostic codes (range 9–60) and different numbers of
procedure codes (range 6–30) for each individual in
these databases, we first analyzed the number of actual
diagnostic codes and procedure codes for each
hospitalization. Of the 25 SID databases, 19 (AZ, AR,
CA, CO, FL, IA, KY, MD, MI, NV, NJ, NM, NY, NC,
OR, RI, VT, WA, and WV) reported > 15 diagnostic
codes. In none of these 19 states did more than a quarter
of the hospitalizations have > 15 diagnostic codes (range
4.1–24.5%). Of the 25 SID databases, 19 states (AZ, AR,
CA, CO, FL, IA, KY, MD, MA, MI, NV, NJ, NY, NC,
OR, RI, SC, VT, and WA) reported > 6 procedure codes.
In none of these 19 states did more than a tenth of the
hospitalizations have > 6 procedure codes (range 1.6–6.1%).
Thus in our primary analysis, we excluded the 2
states with fewer than 15 diagnostic codes (ME, NE)
(Additional file 1: Figure S1). All states had at least 6
procedure codes. For the remaining states, we only
analyzed the first 15 diagnostic codes and first 6 pro-
cedure codes listed for each hospitalization (i.e. for
states whose database contained additional informa-
tion, we ignored the diagnostic codes in position 16
and above and we ignored procedure codes in pos-
ition 7 and above).
We did not count as AKI-D hospitalizations those hos-
pitalizations with a diagnostic code for ESRD present on
admission (585.6). Thus, in our primary analysis, we
additionally excluded 5 states (CO, MS, NC, UT, WV)
whose SID did not specify whether a diagnosis of ESRD
was present on admission or not) (Additional file 1:
Figure S1). (We did include AKI-D hospitalizations with
diagnosis of ESRD only on discharge but not on
admission.)
Therefore, our primary analysis was based on 18 states
(AZ, AR, CA, FL, IA, KY, MA, MD, MI, NJ, NM, NY,
NV, OR, RI, SC, VT, WA) (Additional file 1: Figure S1).
In 2011, these 18 states accounted for 50% of the coun-
try’s incident ESRD cases [9].
In sensitivity analyses, we used data from all 25 states
we had SID data on but to make ascertainment more
uniform, we only analyzed up to 9 diagnostic codes and
up to 6 procedure codes for each state (all states re-
ported at least these numbers of codes). In this sensitiv-
ity analysis, we used the same AKI-D definition as
above, but we excluded all hospitalizations containing a
diagnostic code for ESRD (585.6) regardless of whether
it was present on admission or not (since for CO, MS,
NC, UT, and WV, we could not tell if a given diagnosis
was present on admission or not).
Determination of incidence of AKI-D per state
To calculate AKI-D incidence, we used as denominator
state populations according to US Census Bureau [10, 11].
We considered AKI-D hospitalization per year as be-
ing equal to number of patients who had AKI-D per year
[12]. We based this on the fact that in the 8 states in
which readmission can be identified (using the ‘Visi-
tLink’ variable in the AR, CA, FL, IA, MA, NM, NY, VT,
and WA databases), only 0.0–8.7% of patients had more
than one AKI-D hospitalization.
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Determination of number of renal recovery cases among
incident ESRD patients
The US Renal Data System (USRDS) is a national regis-
try that includes virtually all patients with treated ESRD
in the United States [13]. We defined renal recovery
among incident ESRD patients as a reported treatment
modality of “recovered function” ≥ 90 days in the absence
of renal transplant or death, within 1 year of dialysis
initiation [1].
In additional sensitivity analyses, we used a broader
definition of recovery, grouping the “recovered function,
” “discontinued dialysis,” and “lost to follow-up” mo-
dalities together as time in a recovered state. Patients
who remained alive in this recovered state for ≥90 days
without a renal transplant were counted as re-
covered [1]. Finally, we also examined only recovery
within 6 months and not 12 months after initiation
of dialysis.
Determination of number of nephrologists per state
To explore whether the absence of renal recovery among
incident ESRD patients might be related to the number of
nephrologists (i.e. supplier-induced demand) and thus
might be a state-level confounder, we also examined if the
number of nephrologists in each state in 2011 was associ-
ated with renal recovery. We determined the number of
nephrologists using the American Medical Association
(AMA) Physician Professional Data (PPD) Statistical Re-
search file [14, 15] which includes current and historical
data for more than 1.4 million physicians, residents, and
medical students in the United States and their mailing
addresses [14, 15]. Physicians known to be retired, de-
ceased, or in a training program through the end of 2011
were excluded.
Statistical approach
The AKI-D incidence and rate of renal recovery among
incident ESRD patients were both expressed as per mil-
lion population (pmp) per year for each state. We used
Pearson correlations to analyze the association between
AKI-D incidence and rate of renal recovery across states.
We repeated our analyses in subgroups defined by sex,
age (45–64, 65–74, ≥75 years). We did not show results
for age 0–44 years old due to small number of outcomes
(for example, 8 of the 18 states had fewer than 10
observed cases of renal recovery among incident ESRD
patients of this age range).
We also did not show results stratified by race/ethni-
city as 10 of the 18 states had fewer than 10 observed
cases of renal recovery among incident, non-Hispanic
black ESRD patients. We also used partial correlation to
analyze AKI-D incidence and the rate of renal recovery
across states adjusted by sex and age groups. (We did
not adjust for race as there was no correlation between
race and AKI-D incidence and no correlation between
race and rate of renal recovery.)
Data were analyzed using SPSS version 23.0 (IBM
SPSS, Chicago, IL). Results were independently con-
firmed using SAS version 9.4 (SAS Institute Inc., Cary,
NC) or STATA version 14.1 (College Station, TX) by
separate analysts.
Results
In our primary analysis using 18 states in 2011, we iden-
tified 38,591 AKI-D hospitalizations and 2,746 incident
ESRD patients with renal recovery (Table 1).
There was clear geographic variation among the states
in both AKI-D incidence and rate of renal recovery
among incident ESRD patients (Fig. 1; Additional file 1:
Table S1). AKI-D incidence ranged from 99.0 pmp in
Vermont to 490.4 pmp in Nevada. While the rate of
renal recovery among incident ESRD patients ranged
from 8.8 pmp in Massachusetts to 29.3 pmp in Florida.
Figure 1a shows the positive correlation between AKI-D
incidence and rate of renal recovery among incident
ESRD patients at the level of the state (unadjusted
r = 0.67; p = 0.002).
In our sensitivity analyses using data from all 25 states
(44,152 AKI-D hospitalizations), we saw a similar posi-
tive correlation between AKI-D incidence and rate of
renal recovery among incident ESRD patients at the
state level (unadjusted r = 0.68; p < 0.001) (Fig. 1b). Simi-
lar results were seen when we used a more liberal defin-
ition of recovery (this resulted in a 1.13-fold increase in
number of patients classified as recovered in the 18
states) (unadjusted r = 0.73, p = 0.001) or when we only
considered cases which recovered within 6 months
(unadjusted r = 0.61, p = 0.006).
In subgroup analyses, there was evidence of correlation
between AKI-D incidence and rate of renal recovery
among incident ESRD patients in all subgroups (Add-
itional file 1: Figure S2, Additional file 1: Figure S3).
In partial correlation analyses, we also found a signifi-
cant and positive correlation between AKI-D incidence
and rate of renal recovery among incident ESRD patients
after adjusting for age (partial correlation r = 0.62;
p < 0.001) and sex (partial correlation r = 0.65; p < 0.001).
There was no statistically significant correlation be-
tween the number of board-certified nephrologists
pmp and rate of renal recovery among incident ESRD
patients (r = − 0.31; p = 0.22).
Discussion
In this national cross-sectional ecological study con-
ducted at the state level, we found a strong correlation
between AKI-D incidence and rate of renal recovery
among incident ESRD patients in 2011. These data sup-
port the hypothesis that AKI-D may be a key driver of
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renal recovery trends among incident patients deemed
to have ESRD.
There are several reasons why AKI-D could be mis-
diagnosed as ESRD. Chronic kidney disease (CKD) is a
strong risk factor for AKI-D and severity of CKD is a
strong predictor of non-recovery after AKI-D [16, 17],
making it challenging for clinicians to predict whether
AKI-D patients will recover sufficiently to be able to
discontinue dialysis or not.
Our findings serve to remind clinicians that some inci-
dent dialysis patients who are labeled as “ESRD” could
potentially recover. Thus, it is important for providers to
understand the details surrounding dialysis initiation,
particularly when patients transfer care to a new out-
patient nephrologist. Extra efforts need to be made to
obtain medical records surrounding dialysis initiation,
including knowledge of pre-AKI level of estimated glom-
erular filtration rate (eGFR) and amount of proteinuria
which are strongly correlated with chances of kidney re-
covery to come off dialysis [17]. Knowing that certain
patients may recover may lead to different clinical deci-
sion-making (e.g., tolerating more liberal blood pressure
targets, avoiding nephrotoxins more aggressively, imple-
menting repeated monitoring of residual renal function
or urine output volume, and making more frequent
nephrologist rounds). Future studies that examine opti-
mal monitoring and treatment of AKI-D patients will be
informative.
Our findings have policy-level implications as well.
National health improvement targets are set using
USRDS data. For example, one of the Healthy People
2020 goals is to reduce ESRD incidence by 10% [18].
Given that thousands of people with incident ESRD each
year may regain enough renal function to discontinue
dialysis, ESRD incidence estimates corrected for recovery
might be considered as a superior metric to track disease
burden. In addition, given that many AKI-D patients
recover only after several months [16, 19], it may be un-
reasonable to expect clinicians to classify definitively
whether a patient has ESRD or not as soon as he or she
transitions to outpatient dialysis (via the CMS 2728 form
[20] used to register patients into the USRDS ESRD
database). Perhaps a “follow-up CMS 2728” form to
confirm ESRD status would be beneficial to confirm
ESRD for insurance and other considerations.
Further research into regional variation in rates of
acute and chronic kidney disease that may shed light
into pathophysiology and help identify ways to improve
care. For example, studies of the impact of climate
differences on AKI incidence may be fruitful [21, 22].
Other possibilities include different causes of AKI by re-
gion or the contribution of patient case-mix to recovery
after AKI.
Strengths of our study include our large sample of
hospitalization data from 19 states (and sensitivity ana-
lysis including 25 states) and the nationally comprehen-
sive USRDS data. We strove for accurate capture of
AKI-D cases by excluding patients with an ESRD diag-
nosis on admission. We also checked readmission codes
of hospitalizations to ensure that it was appropriate to
consider AKI-D hospitalization incidence as represen-
ting AKI-D incidence. It is also reassuring that our
primary, subgroup, and sensitivity analyses yielded
similar results.
Table 1 Characteristics of dialysis-requiring acute kidney injury (AKI-D) hospitalizations and recovered end-stage renal disease (ESRD)
patients across 18 states in 2011
AKI-D Recovered ESRD
N 38,591 2,746
Median age, yrs. (25, 75%) 66 (54, 77)a 64 (53, 73)
Male % 58.1 61.1
Race/ethnicity
Non-Hispanic black, % 14.7 16.0
Non-Hispanic white, % 63.7 64.2
Hispanic, % 11.4 15.5
Asian, % 3.2 3.4
Missing, % 4.0 0.9
Primary cause of ESRD
Diabetes Mellitus, % / 24.4
Tubular necrosis, % / 24.0
Multiple myeloma or light chain disease, % / 2.8
Acute interstitial nephritis / 2.1
Yrs years
aExcluding one state which only reported age categories
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Several limitations of our study should be noted.
We did not have access to actual clinical data, such
as serum creatinine, but relied on the best-validated
set of ICD-9 diagnostic and procedure codes to define
AKI-D [7, 8]. Some bias and imprecision may have
been introduced into our analyses due to different
SID datasets having a different number of diagnostic
and procedure codes. We only counted renal recovery
cases among those reported to USRDS as having
ESRD. Patients with AKI-D who transitioned to out-
patient dialysis units but who were not reported to
USRDS were not included. Thus, the actual number
of affected patients may be larger. Our analyses were
limited to one calendar year (2011). We did not have
SID data from all 50 states and we were unable to
track readmission across multiple calendar years.
We acknowledge that this is an ecological analysis and
hence subject to ecological fallacy. Our subgroup ana-
lyses by age and gender provide some reassuring data
(i.e. we did not observe that all the AKI-D cases were in
men and all the recovered ESRD cases were in women
in a given state). We do not have individual patient level
data (including accurate information regarding under-
lying etiology of AKI-D) and were limited in what we
could adjust for on a state-level. It is possible that our
results are confounded by state-level difference in prac-
tice or policy which would increase both AKI-D inci-
dence and likelihood of recovery from ESRD within a
A
B
Fig. 1 Dialysis-requiring acute kidney injury (AKI-D) incidence per million population vs. rate of renal recovery among incident end-stage renal
disease (ESRD) patients per million population by state in 2011. a Primary analysis (18 states) (also see Additional files 1: Table S1), b Sensitivity
analysis (25 states)
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state. However, we are not aware of any information
suggesting there are important geographic variations in
pertinent practice or policy by state. It is possible that
practices could be inconsistent across geographic regions
and could possibly have influenced our results, for ex-
ample, earlier dialysis in the course of AKI in one state
more than another would inflate number of AKI-D cases
as well as increase the number of ESRD patients who
eventually recover. The lack of correlation between the
number of nephrologists and AKI-D incidence (arguing
against supplier-induced demand) provides some re-
assurance. Furthermore, we believe our conclusion from
this ecological study that AKI-D may be a key driver of
renal recovery trends among incident patients deemed
to have ESRD is strengthened by biological plausibility.
Patients arrive at ESRD through only one of two possible
disease pathways—slowly progressive CKD or AKI-D
(not infrequently superimposed on CKD). The latter
may recover vs. the former will not. Thus it is not
surprising that states which have higher rates of AKI-D
pmp also have higher rates of recovery from AKI-D pmp.
Conclusions
Renal recovery among incident ESRD patients is not un-
common but few research publications have focused on
this phenomenon and its implications for reporting and
for setting public policy. To our knowledge, our study is
the first to describe a geographic correlation between
AKI-D incidence and renal recovery rates among pa-
tients starting maintenance dialysis at a state level. Our
findings suggest that AKI-D incidence is an important
driver of renal recovery rates among incident ESRD
patients and raise important considerations regarding
optimal care for AKI-D patients who continue to require
dialysis after hospital discharge.
Additional file
Additional file 1: Figure S1. Flow diagram showing selection of state
for data analysis. Figure S2. Dialysis-requiring acute kidney injury (AKI-D)
incidence vs. rate of renal recovery among incident end-stage renal
disease (ESRD) patients per million population across states by sex. A)
male, B) female. Figure S3. Dialysis-requiring acute kidney injury (AKI-D)
incidence vs. rate of renal recovery among incident end-stage renal
disease (ESRD) patients per million population across states by age
group. A) age 45-64 years, B) age 65-74 years, C) age 75 years or older.
Table S1. The number of dialysis-requiring acute kidney injury (AKI-D)
hospitalization, AKI-D incidence, the number of renal recovery cases
among incident end stage renal disease (ESRD) patients, and renal
recovery rate among incident ESRD patients in 18 states. (DOCX 499 kb)
Abbreviations
AKI-D: Acute kidney injury requiring dialysis; AMA: The American Medical
Association (AMA); AR: Arkansas; AZ: Arizona; CA: California; CO: Colorado;
eGFR: Estimated glomerular filtration rate; ESRD: End stage renal disease;
FL: Florida; HCUP: The Healthcare Cost and Utilization Project; IA: Iowa;
ICD-9: International Classification of Diseases Ninth Revision; KY: Kentucky;
MA: Massachusetts; MD: Maryland; ME: Maine; MI: Michigan; MS: Mississippi;
NC: North Carolina; NE: Nebraska; NJ: New Jersey; NM: New Mexico;
NV: Nevada; NY: New York; OR: Oregon; PPD: Physician Professional Data;
RI: Rhode Island; SC: South Carolina; SID: State Inpatient Databases;
USRDS: The US Renal Data System; UT: Utah; VT: Vermont; WA: Washington;
WV: West Virginia
Acknowledgements
The CDC CKD Surveillance Team consists of group members led by University
of California, San Francisco [Neil Powe (PI), Tanushree Banerjee, Delphine Tuot,
Chi-yuan Hsu, Charles McCulloch, Deidra Crews, Raymond Hsu, Vanessa Grubbs,
Kirsten Bibbins-Domingo],the University of Michigan [Rajiv Saran (PI), Zubin
Modi, Debbie Gipson, Vahakn Shahinian, Brenda Gillespie, Hal Morgenstern,
Michael Heung, William Herman, Jennifer Bragg-Gresham, Austin Stack, Rajesh
Balkrishnan, Jerry Yee, Diane Steffick, Xiaosong Zhang, Jie Xiang, Yun Han,
Maggie Yin, Kara Zivin, Emily Ginier, Vivian Kurtz, April Wyncott] and Centers for
Disease Control and Prevention [Nilka Ríos Burrows (Technical Advisor), Mark
Eberhardt, LaShaundra Everhart, Juanita Mondesire, Priti Patel, Meda Pavkov,
Deborah Rolka, Sharon Saydah Larry Waller].
Disclaimer
The findings and conclusions in this report are those of the authors and do
not necessarily represent the official position of the Centers for Disease
Control and Prevention. And the data reported here have been supplied by
the United States Renal Data System (USRDS). The interpretation and
reporting of these data are the responsibility of the author(s) and in no way
should be seen as an official policy or interpretation of the U.S. government.
Authors’ contributions
Research idea and study design: ZC, BJL, CEM, RKH, NRP, CYH; data analysis/
interpretation: ZC, BJL, CEM, NRB, MH, RKH, MEP, NRP, RS, VS, CYH; statistical
analysis: ZC, BJL, CEM, CYH; supervision or mentorship: NRP, RS, CYH. Each
author contributed important intellectual content during manuscript drafting
or revision and accepts accountability for the overall work by ensuring that
questions pertaining to the accuracy or integrity of any portion of the work
are appropriately investigated and resolved. All authors read and approved
the final manuscript.
Funding
This work was supported by contract NU58DP006255–01-00 of the Centers
for Disease Control and Prevention. Interpretation of data and reviews of the
manuscript were done in part on Government time. Additional funding
include International Society of Nephrology fellowship and National Natural
Science Foundation of China grant 81600590 for ZC; National Institutes of
Health (NIH) grant F32 DK115030 for BJL; NIH grants K23 DK100468 and R03
DK111881 for RKH; NIH grants K24 DK92291 and R01 DK114014 for CYH. The
funding body had no role in the design of the study and collection, analysis,
and interpretation of data and in writing the manuscript.
Availability of data and materials
The data that support the findings of this study are available from the
United States Renal Data System (USRDS) but governed by a USRDS
Agreement for Release of Data (DUA 2017–14).
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Author details
1Division of Nephrology, Ruijin Hospital Affiliated to Shanghai Jiaotong
University School of Medicine, Shanghai, China. 2Division of Nephrology,
Department of Medicine, University of California, San Francisco, 533
Parnassus Ave, U404, Box 0532, San Francisco, CA 94143-0532, USA. 3Houston
Kidney Consultants, Houston, TX, USA. 4Houston Methodist Institute for
Academic Medicine, Houston, TX, USA. 5Department of Epidemiology and
Biostatistics, University of California, San Francisco, CA, USA. 6Division of
Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA,
Chen et al. BMC Nephrology          (2019) 20:342 Page 6 of 7
USA. 7Division of Nephrology, Department of Medicine, University of
Michigan, Ann Arbor, MI, USA. 8UCSF Center for Vulnerable Populations,
Department of Medicine, University of California, San Francisco, CA, USA.
9Department of Medicine, San Francisco General Hospital, San Francisco, CA,
USA. 10Kidney Epidemiology and Cost Center, University of Michigan, Ann
Arbor, MI, USA.
Received: 7 May 2019 Accepted: 22 July 2019
References
1. Lee BJ, Johansen KL, McCulloch CE, Hsu CY. Potential impact of Medicare
payment policy on misclassification of Dialysis-requiring acute kidney injury as
ESRD: a National Temporal Trend Analysis. Am J Kidney Dis. 2018;72(2):311–3.
2. Mohan S, Huff E, Wish J, et al. Recovery of renal function among ESRD
patients in the US medicare program. PLoS One. 2013;8(12):e83447.
3. HCUP State Inpatient Databases (SID). Healthcare Cost and Utilization
Project (HCUP). 2005–2009. Agency for Healthcare Research and Quality R,
MD. www.hcup-us.ahrq.gov/sidoverview.jsp. Accessed 14 Sept 2018.
4. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical
mortality in the United States. N Engl J Med. 2002;346(15):1128–37.
5. Jain NB, Ayers GD, Peterson EN, et al. Traumatic spinal cord injury in the
United States, 1993-2012. JAMA. 2015;313(22):2236–43.
6. Hsu RK, McCulloch CE, Ku E, Dudley RA, Hsu CY. Regional variation in the
incidence of dialysis-requiring AKI in the United States. Clin J Am Soc
Nephrol. 2013;8(9):1476–81.
7. Waikar SS, Wald R, Chertow GM, et al. Validity of international classification
of diseases, ninth revision, clinical modification codes for acute renal failure.
J Am Soc Nephrol. 2006;17(6):1688–94.
8. Hsu RK, McCulloch CE, Dudley RA, Lo LJ, Hsu CY. Temporal changes in
incidence of dialysis-requiring AKI. J Am Soc Nephrol. 2013;24(1):37–42.
9. 2017 USRDS Annual Data Report Reference Table. https://www.usrds.org/2
017/ref/ESRD_Ref_A_Incidence_2017.xlsx. Accessed September 14,2018.
10. Annual Estimates of the Resident Population for the United States, Regions,
States, and Puerto Rico: April 1, 2010 to July 1, 2017 (NST-EST2017-01).
Accessed 14 Sept 2018.
11. Annual Estimates of the Resident Population for Selected Age Groups by
Sex for the United States, States, Counties and Puerto Rico Commonwealth
and Municipios: April 1, 2010 to July 1, 2016. Accessed 14 Sept2018.
12. Khera R, Angraal S, Couch T, et al. Adherence to methodological standards
in research using the National Inpatient Sample. JAMA. 2017;318(20):2011–8.
13. Saran R RB, Shahinian V, et al. US renal data system 2017 annual data report:
epidemiology of kidney disease in the United States. Am J Kidney Dis. 2018;
71(3S1):A7. https://doi.org/10.1053/j.ajkd.2018.01.002.
14. The American Medical Association Physician Masterfile. https://www.ama
-assn.org/life-career/ama-physician-masterfile. Accessed 14 Sept 2018.
15. The AMA Physician Mailing List. http://www.mmslists.com/physician-lists
-data. Accessed 14 Sept 2018.
16. Hsu CY, Chertow GM, McCulloch CE, Fan D, Ordonez JD, Go AS.
Nonrecovery of kidney function and death after acute on chronic renal
failure. Clin J Am Soc Nephrol. 2009;4(5):891–8.
17. Lee BJ, Go AS, Parikh R, et al. Pre-admission proteinuria impacts risk of non-
recovery after dialysis-requiring acute kidney injury. Kidney Int. 2018;93(4):968–76.
18. Lopes AAS, Port FK. The low birth weight hypothesis as a plausible explanation
for the black/white differences in hypertension, non-insulin dependent
diabetes, and end-stage renal disease. Am J Kidney Dis. 1995;25:350–6.
19. Lo LJ, Go AS, Chertow GM, et al. Dialysis-requiring acute renal failure increases
the risk of progressive chronic kidney disease. Kidney Int. 2009;76(8):893–9.
20. ESRD Medical Evidence Report Medicare Entitlement and/or Patient
registration. https://www.cms.gov/Medicare/CMS-Forms/CMS-Forms/CMS
-Forms-Items/CMS008867.html. Accessed 14 Sept 2018.
21. Bobb JF, Obermeyer Z, Wang Y, Dominici F. Cause-specific risk of hospital
admission related to extreme heat in older adults. JAMA. 2014;312(24):2659–67.
22. McTavish RK, Richard L, McArthur E, et al. Association between high
environmental heat and risk of acute kidney injury among older adults in a
northern climate: a matched case-control study. Am J Kidney Dis. 2018;
71(2):200–8.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Chen et al. BMC Nephrology          (2019) 20:342 Page 7 of 7
